This topic contains a solution. Click here to go to the answer

Author Question: The location of concern in Pennsylvania v. Mimms was a: a. factory. b. vehicle. c. border ... (Read 17 times)

KWilfred

  • Hero Member
  • *****
  • Posts: 570
The location of concern in Pennsylvania v. Mimms was a:
 
  a. factory.
  b. vehicle.
  c. border checkpoint.
  d. stationhouse.

Question 2

In vehicle stops, a drug courier profile may be considered when looking at
 
  a. proof beyond a reasonable doubt.
  b. the preponderance of the evidence.
  c. discrimination.
  d. the totality of circumstances.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emsimon14

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

b

Answer to Question 2

d




KWilfred

  • Member
  • Posts: 570
Reply 2 on: Aug 16, 2018
Great answer, keep it coming :)


tanna.moeller

  • Member
  • Posts: 328
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

The shortest mature adult human of whom there is independent evidence was Gul Mohammed in India. In 1990, he was measured in New Delhi and stood 22.5 inches tall.

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library